Serum electrolytes and renal alterations in HIV-seropositive Mexican subjects
To examine potential risk factors associated with biochemical alterations in renal function in a population diagnosed with HIV/AIDS undergoing antiretroviral treatment.This is an observational, transversal, and relational design study that included 179 HIV-seropositive subjects. Glucose serum, chole...
Saved in:
Published in | Medicine (Baltimore) Vol. 100; no. 20; p. e26016 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Lippincott Williams & Wilkins
21.05.2021
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | To examine potential risk factors associated with biochemical alterations in renal function in a population diagnosed with HIV/AIDS undergoing antiretroviral treatment.This is an observational, transversal, and relational design study that included 179 HIV-seropositive subjects. Glucose serum, cholesterol, triglycerides, total proteins, albumin, creatine, urea, blood urea nitrogen (BUN), and electrolytes levels were determined for each individual. Renal function was evaluated through the glomerular filtration rate (GFR), using the CKD-EPI equation. Chronic kidney disease (CKD) was defined as estimated glomerular filtration rate < 60 mL/min/1.73 m2. Univariate model significant variables, with a 95% confidence interval (CI), were included in a multivariate logistic regression analysis.CKD prevalence in patients was 7.3%, with comorbidities of 7.8% for type 2 diabetes mellitus, 7.3% for arterial hypertension, and 35.2% for dyslipidemia. Additionally, both hypernatremia and hypophosphatemia were detected in 57% (n = 102) of the patients. Multivariate logistic regression suggested that CD4+ T cell count < 200 (P = .02; OR 0.2; CI 95% 0.08-0.8) was associated to hyponatremia; similarly, detectable viral load was associated to hypokalemia (P = .02; OR 5.1; CI 95% 1.2-21.3), hypocalcemia (P = .01; OR 4.1; CI 95% 1.3-12.3), and hypermagnesemia (OR 3.9; CI 95% 1.1-13.6). Patient age was associated to both hypophosphatemia (P = .01; OR 2.4; CI 95% 1.1-5.0) and hypermagnesemia (P = .01; OR 2.8; IC 95% 1.1-7.0), and high creatinine levels were associated to nucleoside reverse transcriptase inhibitor treatment (P = .001; OR 42.5; CI 95% 2.2-806.9). Lastly, high BUN levels were associated to age (P = .03; OR 3.8; CI 95% 1.0-14.4), while GFR 60 to 89 mL/min/1.73 m2 was associated to dyslipidemia (P = .02; OR 2.2; CI 95% 1.1-4.5).CD4+ T cell and viral load were the main factors associated with renal biochemical alterations. |
---|---|
AbstractList | To examine potential risk factors associated with biochemical alterations in renal function in a population diagnosed with HIV/AIDS undergoing antiretroviral treatment.This is an observational, transversal, and relational design study that included 179 HIV-seropositive subjects. Glucose serum, cholesterol, triglycerides, total proteins, albumin, creatine, urea, blood urea nitrogen (BUN), and electrolytes levels were determined for each individual. Renal function was evaluated through the glomerular filtration rate (GFR), using the CKD-EPI equation. Chronic kidney disease (CKD) was defined as estimated glomerular filtration rate < 60 mL/min/1.73 m2. Univariate model significant variables, with a 95% confidence interval (CI), were included in a multivariate logistic regression analysis.CKD prevalence in patients was 7.3%, with comorbidities of 7.8% for type 2 diabetes mellitus, 7.3% for arterial hypertension, and 35.2% for dyslipidemia. Additionally, both hypernatremia and hypophosphatemia were detected in 57% (n = 102) of the patients. Multivariate logistic regression suggested that CD4+ T cell count < 200 (P = .02; OR 0.2; CI 95% 0.08-0.8) was associated to hyponatremia; similarly, detectable viral load was associated to hypokalemia (P = .02; OR 5.1; CI 95% 1.2-21.3), hypocalcemia (P = .01; OR 4.1; CI 95% 1.3-12.3), and hypermagnesemia (OR 3.9; CI 95% 1.1-13.6). Patient age was associated to both hypophosphatemia (P = .01; OR 2.4; CI 95% 1.1-5.0) and hypermagnesemia (P = .01; OR 2.8; IC 95% 1.1-7.0), and high creatinine levels were associated to nucleoside reverse transcriptase inhibitor treatment (P = .001; OR 42.5; CI 95% 2.2-806.9). Lastly, high BUN levels were associated to age (P = .03; OR 3.8; CI 95% 1.0-14.4), while GFR 60 to 89 mL/min/1.73 m2 was associated to dyslipidemia (P = .02; OR 2.2; CI 95% 1.1-4.5).CD4+ T cell and viral load were the main factors associated with renal biochemical alterations.ABSTRACTTo examine potential risk factors associated with biochemical alterations in renal function in a population diagnosed with HIV/AIDS undergoing antiretroviral treatment.This is an observational, transversal, and relational design study that included 179 HIV-seropositive subjects. Glucose serum, cholesterol, triglycerides, total proteins, albumin, creatine, urea, blood urea nitrogen (BUN), and electrolytes levels were determined for each individual. Renal function was evaluated through the glomerular filtration rate (GFR), using the CKD-EPI equation. Chronic kidney disease (CKD) was defined as estimated glomerular filtration rate < 60 mL/min/1.73 m2. Univariate model significant variables, with a 95% confidence interval (CI), were included in a multivariate logistic regression analysis.CKD prevalence in patients was 7.3%, with comorbidities of 7.8% for type 2 diabetes mellitus, 7.3% for arterial hypertension, and 35.2% for dyslipidemia. Additionally, both hypernatremia and hypophosphatemia were detected in 57% (n = 102) of the patients. Multivariate logistic regression suggested that CD4+ T cell count < 200 (P = .02; OR 0.2; CI 95% 0.08-0.8) was associated to hyponatremia; similarly, detectable viral load was associated to hypokalemia (P = .02; OR 5.1; CI 95% 1.2-21.3), hypocalcemia (P = .01; OR 4.1; CI 95% 1.3-12.3), and hypermagnesemia (OR 3.9; CI 95% 1.1-13.6). Patient age was associated to both hypophosphatemia (P = .01; OR 2.4; CI 95% 1.1-5.0) and hypermagnesemia (P = .01; OR 2.8; IC 95% 1.1-7.0), and high creatinine levels were associated to nucleoside reverse transcriptase inhibitor treatment (P = .001; OR 42.5; CI 95% 2.2-806.9). Lastly, high BUN levels were associated to age (P = .03; OR 3.8; CI 95% 1.0-14.4), while GFR 60 to 89 mL/min/1.73 m2 was associated to dyslipidemia (P = .02; OR 2.2; CI 95% 1.1-4.5).CD4+ T cell and viral load were the main factors associated with renal biochemical alterations. To examine potential risk factors associated with biochemical alterations in renal function in a population diagnosed with HIV/AIDS undergoing antiretroviral treatment. This is an observational, transversal, and relational design study that included 179 HIV-seropositive subjects. Glucose serum, cholesterol, triglycerides, total proteins, albumin, creatine, urea, blood urea nitrogen (BUN), and electrolytes levels were determined for each individual. Renal function was evaluated through the glomerular filtration rate (GFR), using the CKD-EPI equation. Chronic kidney disease (CKD) was defined as estimated glomerular filtration rate < 60 mL/min/1.73 m 2 . Univariate model significant variables, with a 95% confidence interval (CI), were included in a multivariate logistic regression analysis. CKD prevalence in patients was 7.3%, with comorbidities of 7.8% for type 2 diabetes mellitus, 7.3% for arterial hypertension, and 35.2% for dyslipidemia. Additionally, both hypernatremia and hypophosphatemia were detected in 57% (n = 102) of the patients. Multivariate logistic regression suggested that CD4+ T cell count < 200 ( P = .02; OR 0.2; CI 95% 0.08–0.8) was associated to hyponatremia; similarly, detectable viral load was associated to hypokalemia ( P = .02; OR 5.1; CI 95% 1.2–21.3), hypocalcemia ( P = .01; OR 4.1; CI 95% 1.3–12.3), and hypermagnesemia (OR 3.9; CI 95% 1.1–13.6). Patient age was associated to both hypophosphatemia ( P = .01; OR 2.4; CI 95% 1.1–5.0) and hypermagnesemia ( P = .01; OR 2.8; IC 95% 1.1–7.0), and high creatinine levels were associated to nucleoside reverse transcriptase inhibitor treatment ( P = .001; OR 42.5; CI 95% 2.2–806.9). Lastly, high BUN levels were associated to age ( P = .03; OR 3.8; CI 95% 1.0–14.4), while GFR 60 to 89 mL/min/1.73 m 2 was associated to dyslipidemia ( P = .02; OR 2.2; CI 95% 1.1–4.5). CD4+ T cell and viral load were the main factors associated with renal biochemical alterations. To examine potential risk factors associated with biochemical alterations in renal function in a population diagnosed with HIV/AIDS undergoing antiretroviral treatment.This is an observational, transversal, and relational design study that included 179 HIV-seropositive subjects. Glucose serum, cholesterol, triglycerides, total proteins, albumin, creatine, urea, blood urea nitrogen (BUN), and electrolytes levels were determined for each individual. Renal function was evaluated through the glomerular filtration rate (GFR), using the CKD-EPI equation. Chronic kidney disease (CKD) was defined as estimated glomerular filtration rate < 60 mL/min/1.73 m2. Univariate model significant variables, with a 95% confidence interval (CI), were included in a multivariate logistic regression analysis.CKD prevalence in patients was 7.3%, with comorbidities of 7.8% for type 2 diabetes mellitus, 7.3% for arterial hypertension, and 35.2% for dyslipidemia. Additionally, both hypernatremia and hypophosphatemia were detected in 57% (n = 102) of the patients. Multivariate logistic regression suggested that CD4+ T cell count < 200 (P = .02; OR 0.2; CI 95% 0.08-0.8) was associated to hyponatremia; similarly, detectable viral load was associated to hypokalemia (P = .02; OR 5.1; CI 95% 1.2-21.3), hypocalcemia (P = .01; OR 4.1; CI 95% 1.3-12.3), and hypermagnesemia (OR 3.9; CI 95% 1.1-13.6). Patient age was associated to both hypophosphatemia (P = .01; OR 2.4; CI 95% 1.1-5.0) and hypermagnesemia (P = .01; OR 2.8; IC 95% 1.1-7.0), and high creatinine levels were associated to nucleoside reverse transcriptase inhibitor treatment (P = .001; OR 42.5; CI 95% 2.2-806.9). Lastly, high BUN levels were associated to age (P = .03; OR 3.8; CI 95% 1.0-14.4), while GFR 60 to 89 mL/min/1.73 m2 was associated to dyslipidemia (P = .02; OR 2.2; CI 95% 1.1-4.5).CD4+ T cell and viral load were the main factors associated with renal biochemical alterations. |
Author | Garza Tovar, Oscar Antonio Pérez, María Elena Gutiérrez Robledo, Ivonne Urraza Pérez, Alberto Alejandro Miranda Galarza, Faviel F. González Márquez, Francisco Carlos López |
AuthorAffiliation | Departamento de Inmunobiología Molecular, Centro de Investigación Biomédica, Facultad de Medicina Universidad Autónoma de Coahuila High Specialty Medical Unit (UMAE) # 71, Mexican Social Security Institute, Torreón, Coahuila, México |
AuthorAffiliation_xml | – name: Departamento de Inmunobiología Molecular, Centro de Investigación Biomédica, Facultad de Medicina Universidad Autónoma de Coahuila – name: High Specialty Medical Unit (UMAE) # 71, Mexican Social Security Institute, Torreón, Coahuila, México – name: b High Specialty Medical Unit (UMAE) # 71, Mexican Social Security Institute, Torreón, Coahuila, México – name: a Departamento de Inmunobiología Molecular, Centro de Investigación Biomédica, Facultad de Medicina Universidad Autónoma de Coahuila |
Author_xml | – sequence: 1 givenname: Oscar Antonio surname: Garza Tovar fullname: Garza Tovar, Oscar Antonio organization: Departamento de Inmunobiología Molecular, Centro de Investigación Biomédica, Facultad de Medicina Universidad Autónoma de Coahuila – sequence: 2 givenname: Alberto Alejandro Miranda surname: Pérez fullname: Pérez, Alberto Alejandro Miranda organization: Departamento de Inmunobiología Molecular, Centro de Investigación Biomédica, Facultad de Medicina Universidad Autónoma de Coahuila – sequence: 3 givenname: María Elena Gutiérrez surname: Pérez fullname: Pérez, María Elena Gutiérrez organization: Departamento de Inmunobiología Molecular, Centro de Investigación Biomédica, Facultad de Medicina Universidad Autónoma de Coahuila – sequence: 4 givenname: Ivonne Urraza surname: Robledo fullname: Robledo, Ivonne Urraza organization: High Specialty Medical Unit (UMAE) # 71, Mexican Social Security Institute, Torreón, Coahuila, México – sequence: 5 givenname: Faviel F. González surname: Galarza fullname: Galarza, Faviel F. González organization: Departamento de Inmunobiología Molecular, Centro de Investigación Biomédica, Facultad de Medicina Universidad Autónoma de Coahuila – sequence: 6 givenname: Francisco Carlos López surname: Márquez fullname: Márquez, Francisco Carlos López organization: Departamento de Inmunobiología Molecular, Centro de Investigación Biomédica, Facultad de Medicina Universidad Autónoma de Coahuila |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/34011103$$D View this record in MEDLINE/PubMed |
BookMark | eNp9UcluFDEQtVAQmQS-AAn1kUuH8tZuX5BQEkikjDiwXC23u4Zx8NiD3Z2Qv8fJJCw5UJJVUvkt0nsHZC-miIS8pHBEQas3y5Mj-DOsA9o9IQsqeddK3Yk9sqhX2SqtxD45KOUSgHLFxDOyzwVQSoEvyPIT5nnTYEA35RRuJiyNjWOTMdrQ2DBhtpNPsTQ-NmfnX9uCOW1T8ZO_wmaJP72zsSnzcFkFynPydGVDwRf3-5B8eX_6-fisvfj44fz43UXrhATR9kKNIKwCgXIckHVUUo7jIKxmTDGunBiGjvYrzeXYDyNzMHaAbOVkRVjND8nbne52HjY4OoxTtsFss9_YfGOS9ebfn-jX5lu6Mn1NoOZUBV7fC-T0Y8YymY0vDkOwEdNcDJNMa8qFggp99bfXb5OHDCtA7wAup1Iyrozz011o1doHQ8Hc9mWWJ-ZxX5XLH3Ef5P_PEjvWdbotqHwP8zVms8ba1_oOLpVmLQNGQdbX1ksv-C9jIqdv |
CitedBy_id | crossref_primary_10_3389_fcvm_2022_968184 crossref_primary_10_1161_CIRCRESAHA_124_323948 |
Cites_doi | 10.2337/dc20-S002 10.1038/nrneph.2009.141 10.18203/2320-6012.ijrms20183276 10.1016/j.kint.2017.11.007 10.1016/j.nefro.2019.01.009 10.1001/jama.1990.03440070061033 10.5897/AJCPATH15.001 10.1186/s12882-017-0470-4 10.1093/ndt/gfr657 10.1007/s11904-005-0002-x 10.1097/QAI.0b013e318222f461 10.1016/j.bjid.2018.05.001 10.1371/journal.pone.0111077 10.1097/QAI.0000000000000259 10.1089/aid.2010.0345 10.1371/journal.pone.0093748 10.4172/2161-0681.1000134 10.3947/ic.2017.49.3.194 10.1159/000092247 10.1038/nrneph.2013.143 10.5414/CNP83S032 10.5527/wjn.v5.i1.33 10.1016/0002-9343(93)90179-S 10.1056/NEJMra1508467 10.1053/j.ackd.2009.08.006 10.5527/wjn.v4.i3.388 10.1093/ndt/gfm836 10.1371/journal.pone.0010687 10.7326/0003-4819-112-1-35 10.1186/s12879-017-2191-5 10.1056/NEJM199302043280508 |
ContentType | Journal Article |
Copyright | Lippincott Williams & Wilkins Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. 2021 |
Copyright_xml | – notice: Lippincott Williams & Wilkins – notice: Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. – notice: Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. 2021 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM |
DOI | 10.1097/MD.0000000000026016 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1536-5964 |
EndPage | e26016 |
ExternalDocumentID | PMC8137016 34011103 10_1097_MD_0000000000026016 00005792-202105210-00084 |
Genre | Journal Article Observational Study |
GeographicLocations | Mexico |
GeographicLocations_xml | – name: Mexico |
GroupedDBID | --- .-D .XZ .Z2 01R 0R~ 354 40H 4Q1 4Q2 4Q3 5GY 5RE 5VS 71W 77Y 7O~ AAAAV AAGIX AAHPQ AAIQE AAMOA AAQKA AARTV AASCR AAWTL AAXQO AAYEP ABASU ABBUW ABCQX ABDIG ABFRF ABOCM ABVCZ ABXVJ ABZAD ABZZY ACDDN ACEWG ACGFO ACGFS ACILI ACLDA ACWDW ACWRI ACXJB ACXNZ ACZKN ADGGA ADHPY ADNKB ADPDF AE6 AEFWE AENEX AFBFQ AFDTB AGOPY AHOMT AHQNM AHVBC AIJEX AINUH AJCLO AJIOK AJNWD AJNYG AJZMW AKCTQ AKULP ALKUP ALMA_UNASSIGNED_HOLDINGS ALMTX AMJPA AMKUR AMNEI AOHHW AOQMC BQLVK CS3 DIWNM DU5 E.X EBS EEVPB ERAAH EX3 F2K F2L F2M F2N F5P FCALG FD6 FIJ FL- GNXGY GQDEL GROUPED_DOAJ H0~ HLJTE HYE HZ~ H~9 IKREB IKYAY IN~ IPNFZ JK3 JK8 K8S KD2 KMI KQ8 L-C N9A N~7 N~B O9- OAG OAH OB2 OHH OK1 OL1 OLB OLG OLH OLU OLV OLY OLZ OPUJH OUVQU OVD OVDNE OVEED OVIDH OVLEI OWV OWW OWZ OXXIT P2P RIG RLZ RPM RXW S4R S4S TAF TEORI TSPGW UNMZH V2I VVN W3M WOQ WOW X3V X3W XYM YFH YOC ZFV ZY1 AAYXX ADSXY CITATION 8L- ACIJW AWKKM CGR CUY CVF ECM EIF NPM ODA 7X8 5PM |
ID | FETCH-LOGICAL-c4504-847d04a704e5dbe261513edb4a9227237c4bb618f935d8bd2c0d60e2fc5a92a93 |
ISSN | 0025-7974 1536-5964 |
IngestDate | Thu Aug 21 14:34:14 EDT 2025 Thu Jul 10 21:58:41 EDT 2025 Wed Feb 19 02:24:44 EST 2025 Tue Aug 05 12:06:25 EDT 2025 Thu Apr 24 23:04:47 EDT 2025 Fri May 16 03:48:34 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 20 |
Language | English |
License | Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC), where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc/4.0 |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c4504-847d04a704e5dbe261513edb4a9227237c4bb618f935d8bd2c0d60e2fc5a92a93 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Undefined-3 |
ORCID | 0000-0003-2939-7411 |
OpenAccessLink | http://dx.doi.org/10.1097/MD.0000000000026016 |
PMID | 34011103 |
PQID | 2529913470 |
PQPubID | 23479 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_8137016 proquest_miscellaneous_2529913470 pubmed_primary_34011103 crossref_citationtrail_10_1097_MD_0000000000026016 crossref_primary_10_1097_MD_0000000000026016 wolterskluwer_health_00005792-202105210-00084 |
PublicationCentury | 2000 |
PublicationDate | 20210521 2021-05-21 2021-May-21 |
PublicationDateYYYYMMDD | 2021-05-21 |
PublicationDate_xml | – month: 05 year: 2021 text: 20210521 day: 21 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: Hagerstown, MD |
PublicationTitle | Medicine (Baltimore) |
PublicationTitleAlternate | Medicine (Baltimore) |
PublicationYear | 2021 |
Publisher | Lippincott Williams & Wilkins |
Publisher_xml | – name: Lippincott Williams & Wilkins |
References | Obum-Nnadi (R6-20250504) 2013; 03 Domingo (R29-20250504) 2019; 39 Ugwuja (R34-20250504) 2012; 2 Vitting (R40-20250504) 1990; 263 Epstein (R47-20250504) 1993; 328 Braconnier (R38-20250504) 2017; 17 Emejulu (R35-20250504) 2011; 5 Swanepoel (R5-20250504) 2018; 93 Afhami (R7-20250504) 2007; 10 Olaniyan (R36-20250504) 2004; 1 Ibrahim (R20-20250504) 2012; 27 Emem (R24-20250504) 2008; 23 Fabian (R23-20250504) 2009; 5 Naicker (R2-20250504) 2015; 83 Dao (R8-20250504) 2011; 27 Cristelli (R3-20250504) 2017; 18 Ando (R26-20250504) 2015; 4 Damor (R32-20250504) 2018; 6 Kalyesubula (R1-20250504) 2014; 67 Berggren (R10-20250504) 2005; 2 Schneider (R15-20250504) 2008; 57 Glassock (R9-20250504) 1990; 112 Eshiet (R30-20250504) 2015; 4 Heimburger (R42-20250504) 2010; 5 Levin (R16-20250504) 2013; 3 Juega-Mariño (R27-20250504) 2017; 96 CN (R43-20250504) 2013; 03 Delanaye (R17-20250504) 2013; 9 Winston (R46-20250504) 2010; 17 Santiago (R22-20250504) 2014; 9 Wikman (R41-20250504) 2010; 13 Nwauche (R33-20250504) 2019; 8 Levey (R12-20250504) 2002; 39 Xu (R37-20250504) 2014; 9 González-López (R21-20250504) 2014; 34 Bagnis (R45-20250504) 2006; 103 Cohen (R4-20250504) 2017; 377 Association (R13-20250504) 2020; 43 Tang (R39-20250504) 1993; 94 Musso (R11-20250504) 2016; 5 Samson (R31-20250504) 2018; 7 Kim (R28-20250504) 2017; 49 Estrella (R19-20250504) 2011; 57 Cristelli (R25-20250504) 2018; 22 |
References_xml | – volume: 39 issue: (2 SUPPL. 1) year: 2002 ident: R12-20250504 article-title: K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification publication-title: Am J Kidney Dis – volume: 3 start-page: 01 year: 2013 ident: R16-20250504 article-title: KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease publication-title: Kidney Int Suppl – volume: 43 start-page: S14 issue: (Supplement 1) year: 2020 ident: R13-20250504 article-title: 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2020 publication-title: Diabetes Care doi: 10.2337/dc20-S002 – volume: 5 start-page: 591 year: 2009 ident: R23-20250504 article-title: HIV and kidney disease in sub-Saharan Africa publication-title: Nat Rev Nephrol doi: 10.1038/nrneph.2009.141 – volume: 6 start-page: 2818 year: 2018 ident: R32-20250504 article-title: A prospective study of serum electrolyte disorders and their clinical manifestation in HIV patients publication-title: Int J Res Med Sci doi: 10.18203/2320-6012.ijrms20183276 – volume: 93 start-page: 545 year: 2018 ident: R5-20250504 article-title: Kidney disease in the setting of HIV infection: conclusions from a kidney disease: improving global outcomes (KDIGO) controversies conference publication-title: Kidney Int doi: 10.1016/j.kint.2017.11.007 – volume: 39 start-page: 497 year: 2019 ident: R29-20250504 article-title: Predictive factors of renal impairment in HIV-infected patients on antiretroviral therapy: results from the VACH longitudinal cohort study publication-title: Nefrología doi: 10.1016/j.nefro.2019.01.009 – volume: 263 start-page: 973 year: 1990 ident: R40-20250504 article-title: Frequency of hyponatremia and nonosmolar vasopressin release in the acquired immuno deficiency syndrome publication-title: J Am Med Assoc doi: 10.1001/jama.1990.03440070061033 – volume: 4 start-page: 01 year: 2015 ident: R30-20250504 article-title: Plasma urea and electrolytes profile in different stages of hiv infection in Ekpoma publication-title: Nigeria African J Cell Pathol doi: 10.5897/AJCPATH15.001 – volume: 18 start-page: 01 year: 2017 ident: R3-20250504 article-title: Estimation of renal function by CKD-EPI versus MDRD in a cohort of HIV-infected patients: a cross-sectional analysis publication-title: BMC Nephrol doi: 10.1186/s12882-017-0470-4 – volume: 27 start-page: 2291 year: 2012 ident: R20-20250504 article-title: Comparison of CKD-EPI and MDRD to estimate baseline renal function in HIV-positive patients publication-title: Nephrol Dial Transplant doi: 10.1093/ndt/gfr657 – volume: 8 start-page: 01 year: 2019 ident: R33-20250504 article-title: Comparative study on the electrolyte levels of HIV/AIDS patients on high active antiretroviral therapy (HAART) in owerri metropolis publication-title: South Eastern Nigeria Int STD Res Rev – volume: 2 start-page: 109 year: 2005 ident: R10-20250504 article-title: HIV-associated renal disorders: recent insights into pathogenesis and treatment publication-title: Curr HIV/AIDS Rep doi: 10.1007/s11904-005-0002-x – volume: 10 start-page: 335 year: 2007 ident: R7-20250504 article-title: Renal disorders in HIV-infected patients publication-title: Arch Iran Med – volume: 57 start-page: 380 year: 2011 ident: R19-20250504 article-title: Chronic kidney disease and estimates of kidney function in HIV infection: a cross-sectional study in the multicenter AIDS cohort study publication-title: J Acquir Immune Defic Syndr doi: 10.1097/QAI.0b013e318222f461 – volume: 03 start-page: 03 year: 2013 ident: R6-20250504 article-title: Assay of the level of calcium, magnesium and inorganic phosphorus in HIV infected patients in Owerri publication-title: Southeast Nigeria J Clin Exp Pathol – volume: 22 start-page: 193 year: 2018 ident: R25-20250504 article-title: Prevalence and risk factors of mild chronic renal failure in HIV-infected patients: influence of female gender and antiretroviral therapy publication-title: Brazilian J Infect Dis doi: 10.1016/j.bjid.2018.05.001 – volume: 9 start-page: e111077 year: 2014 ident: R37-20250504 article-title: Moderate/severe hyponatremia increases the risk of death among hospitalized chinese human immunodeficiency virus/acquired immunodeficiency syndrome patients publication-title: PLoS One doi: 10.1371/journal.pone.0111077 – volume: 67 start-page: 68 issue: (Suppl.1) year: 2014 ident: R1-20250504 article-title: HIV-associated renal and genitourinary comorbidities in Africa publication-title: J Acquir Immune Defic Syndr doi: 10.1097/QAI.0000000000000259 – volume: 1 start-page: 29 year: 2004 ident: R36-20250504 article-title: Comparative study of plasma electrolytes (Na, K, Cl, and HCO3) and urea levels in HIV/AIDS and pulmonary tuberculosis infected subjects publication-title: Niger Soc Exp Biol – volume: 27 start-page: 1149 year: 2011 ident: R8-20250504 article-title: Hyponatremia, hypochloremia, and hypoalbuminemia predict an increased risk of mortality during the first year of antiretroviral therapy among HIV-infected Zambian and Kenyan women publication-title: AIDS Res Hum Retroviruses doi: 10.1089/aid.2010.0345 – volume: 9 start-page: e93748 year: 2014 ident: R22-20250504 article-title: Screening for decreased glomerular filtration rate and associated risk factors in a cohort of HIV-infected patients in a middle-income country publication-title: Burdmann EA, ed PLoS One doi: 10.1371/journal.pone.0093748 – volume: 03 start-page: 03 year: 2013 ident: R43-20250504 article-title: Assay of the level of calcium, magnesium and inorganic phosphorus in HIV infected patients in Owerri, southeast Nigeria publication-title: J Clin Exp Pathol doi: 10.4172/2161-0681.1000134 – volume: 49 start-page: 194 year: 2017 ident: R28-20250504 article-title: The prevalence and risk factors of renal insufficiency among Korean HIV-infected patients: the Korea HIV/AIDS cohort study publication-title: Infect Chemother doi: 10.3947/ic.2017.49.3.194 – volume: 103 start-page: 131 year: 2006 ident: R45-20250504 article-title: Changing electrolyte and acido-basic profile in HIV-infected patients in the HAART era publication-title: Nephron - Physiol doi: 10.1159/000092247 – volume: 9 start-page: 513 year: 2013 ident: R17-20250504 article-title: The applicability of eGFR equations to different populations publication-title: Nat Rev Nephrol doi: 10.1038/nrneph.2013.143 – volume: 83 start-page: S32 year: 2015 ident: R2-20250504 article-title: HIV and chronic kidney disease publication-title: Clin Nephrol doi: 10.5414/CNP83S032 – volume: 5 start-page: 33 year: 2016 ident: R11-20250504 article-title: Water, electrolytes, and acid-base alterations in human immunodeficiency virus infected patients publication-title: World J Nephrol doi: 10.5527/wjn.v5.i1.33 – volume: 96 year: 2017 ident: R27-20250504 article-title: Prevalence, evolution, and related risk factors of kidney disease among Spanish HIV-infected individuals publication-title: Med (United States) – volume: 94 start-page: 169 year: 1993 ident: R39-20250504 article-title: Hyponatremia in hospitalized patients with the acquired immunodeficiency syndrome (AIDS) and the AIDS-related complex publication-title: Am J Med doi: 10.1016/0002-9343(93)90179-S – volume: 377 start-page: 2363 year: 2017 ident: R4-20250504 article-title: Kidney diseases associated with human immunodeficiency virus infection publication-title: N Engl J Med doi: 10.1056/NEJMra1508467 – volume: 17 start-page: 19 year: 2010 ident: R46-20250504 article-title: HIV and CKD epidemiology publication-title: Adv Chronic Kidney Dis doi: 10.1053/j.ackd.2009.08.006 – volume: 34 start-page: 126 year: 2014 ident: R21-20250504 article-title: Prevalencia de enfermedad renal crónica en pacientes infectados por el virus de la inmunodeficiencia humana publication-title: Nefrologia – volume: 4 start-page: 388 year: 2015 ident: R26-20250504 article-title: Epidemiology, clinical characteristics, and management of chronic kidney disease in human immunodeficiency virus-infected patients publication-title: World J Nephrol doi: 10.5527/wjn.v4.i3.388 – volume: 23 start-page: 741 year: 2008 ident: R24-20250504 article-title: Renal disease in HIV-seropositive patients in Nigeria: an assessment of prevalence, clinical features and risk factors publication-title: Nephrol Dial Transplant doi: 10.1093/ndt/gfm836 – volume: 5 year: 2010 ident: R42-20250504 article-title: Serum phosphate predicts early mortality in adults starting antiretroviral therapy in lusaka, zambia: a prospective cohort study publication-title: PLoS One doi: 10.1371/journal.pone.0010687 – volume: 7 start-page: 5928 year: 2018 ident: R31-20250504 article-title: Effects of highly active antiretroviral therapy (HAART) on some serum micronutrients and electrolytes levels in HIV infected patients in Southern Nigeria publication-title: Biomed J Sci Tech Res – volume: 112 start-page: 35 year: 1990 ident: R9-20250504 article-title: Human immunodeficiency virus (HIV) infection and the kidney publication-title: Ann Intern Med doi: 10.7326/0003-4819-112-1-35 – volume: 17 year: 2017 ident: R38-20250504 article-title: Hyponatremia is a marker of disease severity in HIV-infected patients: a retrospective cohort study publication-title: BMC Infect Dis doi: 10.1186/s12879-017-2191-5 – volume: 5 start-page: 257 year: 2011 ident: R35-20250504 article-title: Electrolyte abnormalities and renal impairment in asymptomatic HIV-infected patients in Owerri publication-title: South Eastern Nigeria Aust J Basic Appl Sci – volume: 328 start-page: 327 year: 1993 ident: R47-20250504 article-title: The Immunopathogenesis of human immunodeficiency virus infection publication-title: N Engl J Med doi: 10.1056/NEJM199302043280508 – volume: 57 start-page: 01 issue: (RR-10) year: 2008 ident: R15-20250504 article-title: Revised surveillance case definitions for HIV infection among adults, adolescents, and children aged <18 months and for HIV infection and AIDS among children aged 18 months to <13 years--United States, 2008 publication-title: MMWR Recomm Rep – volume: 13 start-page: P150 issue: (Suppl 4) year: 2010 ident: R41-20250504 article-title: Lack of utility of phosphate serum monitoring in HIV-infected patients on a tenofovir-based antiretroviral regimen publication-title: J Int AIDS Soc – volume: 2 start-page: 01 year: 2012 ident: R34-20250504 article-title: A Comparative study of serum electrolytes, total protein, calcium and phosphate among diabetic and HIV/AIDS patients in abakaliki, southeastern publication-title: Nigeria Internet J Lab Med |
SSID | ssj0013724 |
Score | 2.3421655 |
Snippet | To examine potential risk factors associated with biochemical alterations in renal function in a population diagnosed with HIV/AIDS undergoing antiretroviral... |
SourceID | pubmedcentral proquest pubmed crossref wolterskluwer |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | e26016 |
SubjectTerms | Adult Aged Anti-Retroviral Agents - therapeutic use Electrolytes - blood Female Glomerular Filtration Rate - physiology HIV Seropositivity - blood HIV Seropositivity - complications HIV Seropositivity - drug therapy Humans Male Mexico Middle Aged Observational Study Prevalence Renal Insufficiency, Chronic - diagnosis Renal Insufficiency, Chronic - epidemiology Risk Factors Young Adult |
Title | Serum electrolytes and renal alterations in HIV-seropositive Mexican subjects |
URI | https://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=fulltext&D=ovft&AN=00005792-202105210-00084 https://www.ncbi.nlm.nih.gov/pubmed/34011103 https://www.proquest.com/docview/2529913470 https://pubmed.ncbi.nlm.nih.gov/PMC8137016 |
Volume | 100 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLZKJyEkhLhTLlOQeCsZrmPXyWOhhQ4p7KWb9hY5saMVSoLSdkD_Hn-MYztJk66aGH2IqtR1nZ7Px8fn8hmhNwS2xmkaDFzOFHEpINgVwhcuSf1UeCTlUmqHfvhlOD2ln8_Zeafzp5G1tF7FR8lmb13J_0gV7oFcdZXsDSRbdwo34D3IF64gYbj-k4xhoq-_98uTbBa_tQvVpIsrbWKaOPg2VXx6fObCoHKbpaWPHFK_jApcrmPti1k2zdSwjLhr-_M9dDS36bi10-CTKDaiP8svbXr2yTIRheYhAAWR18rWxuAL66IeaS4tsHNHC_VVaJKEfjgvRMMf0G4eChvCH4v-BNZFAVBezcsW0GQbJooXShpv7_GlTtnpnxaF2IimL4MMdBjeFkjXtQWaQNOe23OkKpU8dFlguc5rnY1xA5wEN1SwMiRpe1cHyzocji1ppX3Vrdtc3DtrZJ25WMXsw3G028ktdEBgr0K66ODkbDIZb4NZnND65GB4uIr8KuDv9oylbSBd2fVcTd69-zPXgFp-M3UVDetodh_dK7c1zshi9AHqqOwhul3B6BEKDVSdJlQdkL5joOo0oOrMM2cXqk4JVaeC6mN0-nEy-zB1y5M83IQyTF0wgSSmgmOqmIxBQmBnekrGVASEcOLxhMbxcOCngcekH0uSYDnEiqQJgxYi8J6gbpZn6hlyYok9BSu4FAGjA64CzkCveAFWWBCucA-R6u-LkpLmXp-2soiuEV0Pva2_9MOyvFzf_HUllwi0sQ6xiUzl62VEGJh3ujobxvHUyqnu0KOwlg6w10O8JcG6gWZ6b3-SzS8M47sPGDK_67ZkHdlaaTM-xgPi6jmlq_ENWYRPn9_ssV6gO9tJ-RJ1V8VavQKTexUfGlfVYQnsv_e8zOE |
linkProvider | Ovid |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlR3bbtMw1IJOgkkIcR3laiSUJwyuY9fJQx-qNqMbS0Fqd-EpcmJHTIxkWtoBf885SVooE0jkJZF8cpHPyblfCHklwDTO87DHtHKCSaBgZkxgmMiD3Pgi19aiQz-e9ieHcv9EnbTZFlgLg9Vn1fkbPNV8Gi9wHg4ahvPB_sybRsezQeGNZqPBJ-_j8F1U-6kxS8IbD8rLfOENp3X-ldKhABoAkwYkVF09HcjrZKuvhOYdsvXhKIrGv-INWsj1cFdQsVf9iUL9Nh43PQ6bo-7AtSnDriimV_Mrb30rMfZdfalT338TYLt3yO1W86TDhlTukmuuuEduxG1s_T6JgW0sv9J2Ls7ZD9BBqSksvXB4Wx1Vb7x79LSgk70jBsRbNjlfl47G7jsyVFotU_TsVA_I4W40H01YO2yBZVJxyUBKWS6N5tIpmzqBmo7vbCpNKIQWvs5kmvZ7QR76ygapFRm3fe5EnimAMKH_kHSKsnCPCE0t9x0wWWtCJXvahVoB6v2QO26EdrxLxGr7kqztRI4DMc6SVUQ8Hid_7nmXvF7fdN404vg3-MsVXhL4YTAKYgpXLqtEKJDAWEAL37HT4Gn9QB-sTdCH_C7RGxhcA2Az7s2V4vRz3ZQ7ABqq38s2cJ005azJ3yjy8X_CvyA3J_P4IDnYm75_QrZxFXMZRO8p6Swulu4ZqEiL9HlL3z8BIyMD-g |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlR1rT9sw0GJFQpMmxN5lr0ya8mmeXD_q5EM-oCZdYUtBKjD4FDmxoyEgQaRl499zzqNbxzRp-ZJIPieW73K-9yH0gYJqnOf-AEthKOZAwVgpT2Gae7liNJdaW4N-PB1OjvjeiThZQ53H1CafVVef7K1m0_bBtsOxeuFhsDdzR7NRcOpOo2-zYOoe7HyOajO1DZJwD8JxcOuGQXmTz91wP-jqM8ZhU6SwueoSWg_QuucNCe-h9f3jKAp_-R0k5csmryBqd3WK_v6a1bPsnoB6P87y0Y_S-sCr8zoE_reDbLyFNlsJ1NlpSOYxWjPFE7QRtz72pygG9rG4dNr-OBe3IIs6qtDOtbHTau96Y-VzzgpnsnuMgYjLJvbrxjix-WkZq1MtUmvhqZ6ho3F0OJrgtukCzrggHMNppQlXknAjdGqolXiY0SlXPqWSMpnxNB0OvNxnQnupphnRQ2JongmAUD57jnpFWZiXyEk1YQaYrVa-4ANpfCmABJhPDFFUGtJHtNu-JGsrktvGGBdJ5xmPw-TPPe-jj8tJV01Bjn-Dv-_wksCPY70hqjDlokqogJPYJtLCOl40eFq-kIHWCXIR6yO5gsElgC3KvTpSnH2vi3N7QEP1d_EKrpMmrbVen5A-Be4EyjbITnVev8e3_xP-HdoAek--7k6_vEIP7aANaaCD16g3v16YNyApzdO3LXnfARTSBYY |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Serum+electrolytes+and+renal+alterations+in+HIV-seropositive+Mexican+subjects&rft.jtitle=Medicine+%28Baltimore%29&rft.au=Garza+Tovar%2C+Oscar+Antonio&rft.au=P%C3%A9rez%2C+Alberto+Alejandro+Miranda&rft.au=P%C3%A9rez%2C+Mar%C3%ADa+Elena+Guti%C3%A9rrez&rft.au=Robledo%2C+Ivonne+Urraza&rft.date=2021-05-21&rft.issn=0025-7974&rft.eissn=1536-5964&rft.volume=100&rft.issue=20&rft.spage=e26016&rft_id=info:doi/10.1097%2FMD.0000000000026016&rft.externalDBID=n%2Fa&rft.externalDocID=10_1097_MD_0000000000026016 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0025-7974&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0025-7974&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0025-7974&client=summon |